Send to a Friend Share

Roth Capital Downgrades CollaGenex (CGPI) to Hold

February 29, 2008 9:24 AM EST
CGPI Hot Sheet
Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 7 | New: 23
Roth Capital downgrades CollaGenex (Nasdaq: CGPI) from Buy to Hold. Price target $16.60.

CollaGenex Pharmaceuticals, Inc. (CollaGenex) together with its subsidiaries, is a specialty pharmaceutical company focused on developing and marketing medical therapies to the dermatology market.

You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Roth Capital

Add Your Comment





Follow StreetInsider.com On Twitter